Instil Bio Q1 2024 GAAP EPS $(2.39) Misses $(2.23) Estimate
Portfolio Pulse from Benzinga Newsdesk
Instil Bio reported Q1 2024 GAAP EPS of $(2.39), missing the consensus estimate of $(2.23) by 7.17%.
May 10, 2024 | 11:06 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Instil Bio's Q1 2024 earnings report showed a larger loss per share than analysts expected, missing the consensus estimate by 7.17%.
Earnings misses typically lead to negative investor sentiment in the short term, potentially causing a decrease in stock price as expectations are not met.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100